The FDA, their agendas and changing goal posts, page-41

IMO - Timing will be key in the Vivagel scenario ..... for example; if Vivagel is already launched in ANZ before the FDA meeting and then we do receive advice wanting a new trial it should have less impact on the share price than say if it was advised at present in the current situation of no products on the shelves anywhere ?

It certainly is a struggle to see Vivagel approved by a host of countries for both treatment and prevention based on the same trial data and for the USA to be wanting further information...... as some have said on here, if it is available in many other parts of the world and women are very happy with the results it is likely we could see some sort of ‘powdered milk’ type scenario evolve ?

I guess we will know soon enough .... get that ANZ launch happening Aspen !

It is also a little disappointing that our lawyers haven’t been able to stop the copy cat VIVAgel being sold on Alibaba almost 1 year on

https://m.alibaba.com/trade/search?SearchText=Vivagel

The Alibaba guidelines @antibotter posted on here looked simple enough to have overturned due to copyright infringement, but obviously not to be ?